Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Analgesic Study of Adductor Canal &IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty :A Randomized,Double-controlled,Parallel-controlled,Single-center Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06145165
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:11.205724+00:00
Published At
2024-09-23T00:00:00+00:00
Record Updated At
2024-09-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Liposomal Bupivacaine", "Postoperative Recovery", "Unilateral Knee Arthroplasty"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-09-23"
protocolSection.identificationModule.nctId
"NCT06145165"
protocolSection.identificationModule.officialTitle
"A Analgesic Study of Adductor Canal \u0026IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty \uff1aA Randomized\uff0cDouble-controlled\uff0cParallel-controlled\uff0cSingle-center Study"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Liposomal Bupivacaine (protocolSection.conditionsModule.conditions)
  • Postoperative Recovery (protocolSection.conditionsModule.conditions)
  • Unilateral Knee Arthroplasty (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.